Hannah Rose

Statistics

Publications

Citations

125

H-Index

Active since

2016

Affiliations

Geelong Hospital(Current)

The University of Melbourne

Austin Health

Peter MacCallum Cancer Centre

St Vincent's Hospital Melbourne

Hannah Rose is an author at Geelong Hospital specializing in hematologic malignancy therapy, pharmacotherapy, and hematologic malignancy pharmacotherapy.

Publications per year

2016–2025

Publications

Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma

Constantine S. Tam, Hang Quach, Andrew J. Nicol et al. · Blood Advances · 2020 · 53 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Won Seog Kim, Tae Min Kim, Seok‐Goo Cho et al. · Nature Cancer · 2025 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

(512) The impact of virtual reality on chronic pain

Ted Jones, Todd Moore, Hannah Rose et al. · Journal of Pain · 2016 · 18 citations

Nursing, Behavioral Sciences, Pain Management +13

Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

Joel Wight, Nada Hamad, Belinda A. Campbell et al. · Internal Medicine Journal · 2021 · 10 citations · Full text

Medicine, Hematology, Oncology +17

1–4 of 4